Shukra Pharmaceuticals Limited (shukraphar) Q2 FY27: Management Commentary Highlights Export Growth and Medtech Expansion

Shukra Pharmaceuticals Limited (SHUKRAPHAR) reports Q2 FY27 results with revenue of ₹44.20 crore, highlighting export growth and MedTech expansion.